New drug BLKR201 put to the test in healthy volunteers
NCT ID NCT07501039
First seen Apr 12, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This early-stage study tests whether BLKR201 is safe in 128 healthy adults aged 18 to 55. Participants take the drug or a placebo by mouth and stay at a research unit for monitoring. Researchers also measure how the drug moves through the body and whether food affects its absorption.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Celerion
RECRUITINGLincoln, Nebraska, 68502, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.